PACIFIC BIOSCIENCES OF CALIFORNIA, INC. Pacific Biosciences of California, Inc.
Equities
PACB
US69404D1081
Advanced Medical Equipment & Technology
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.855 USD | +7.85% |
|
-0.01% | -81.35% |
| May. 09 | Earnings Flash (PACB) PACIFIC BIOSCIENCES OF CALIFORNIA Reports Q1 Revenue $38.8M | MT |
| Apr. 22 | JPMorgan Downgrades Pacific Biosciences of California to Neutral From Overweight | MT |
Presenter SpeechDerik De Bruin (Analysts)I'm Derik De Bruin, the Senior Life Sciences and Diag...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Pacific Biosciences of California, Inc. is a life science technology company. It is engaged in designing, developing, and manufacturing advanced sequencing solutions that enable scientists and clinical researchers to resolve genetically complex problems. Its products and technology under development stem from two differentiated core technologies, which include its HiFi long-read sequencing technology and its Sequencing by Binding (SBB) short-read sequencing technology. Its products address solutions across a set of applications, including human genetics, plant and animal sciences, infectious disease and microbiology, oncology, and other emerging applications. It has developed HiFi long-read sequencing based on Single-Molecule Real-Time technology, which accurately detects the nucleotide sequence and epigenetic status of individual DNA molecules. Its Revio, Sequel, Sequel II and Sequel IIe instruments conduct, monitor, and analyze single-molecule biochemical reactions in real time.
Calendar
2024-07-30
- Q2 2024 Earnings Release (Projected)
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
C
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
1.72
USD
Average target price
5.818
USD
Spread / Average Target
+238.27%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -81.35% | 468M | |
| +9.79% | 221B | |
| +8.68% | 186B | |
| +14.60% | 137B | |
| +28.04% | 109B | |
| -0.42% | 63.09B | |
| +15.29% | 52.68B | |
| +4.86% | 50.86B | |
| +6.44% | 42.53B | |
| +7.49% | 37.76B |
- Stock Market
- Equities
- PACB Stock
- News Pacific Biosciences of California, Inc.
- Transcript : Pacific Biosciences of California, Inc. Presents at Bank of America Securities 2023 Healthcare Conference, May-10-2023 09